B
Beverly A. Dixon
Researcher at California State University
Publications - 9
Citations - 381
Beverly A. Dixon is an academic researcher from California State University. The author has contributed to research in topics: Bioaerosol & Aeromonas. The author has an hindex of 8, co-authored 8 publications receiving 345 citations. Previous affiliations of Beverly A. Dixon include California State University, East Bay.
Papers
More filters
Journal ArticleDOI
Enzyme production by obligate intestinal anaerobic bacteria isolated from oscars (Astronotus ocellatus), angelfish (Pterophyllum scalare) and southern flounder (Paralichthys lethostigma)
TL;DR: The purpose of this research was to isolate and identify the obligate anaerobic intestinal flora of the freshwater angelfish, oscars and the marine southern flounder and to identify new undescribed taxa.
Journal ArticleDOI
Determination of emitted airborne microorganisms from a BIO-PAK wastewater treatment plant.
Ewa Korzeniewska,Zofia Filipkowska,Anna Gotkowska-Płachta,Wojciech Janczukowicz,Beverly A. Dixon,Magdalena Czułowska +5 more
TL;DR: Higher species diversity of the family Enterobacteriaceae in the air sampled inside or near the bioreactor may imply a health risk for staff exposed for longer periods of time, although no increased emission of the analysed groups of microorganisms were found outside the WWTP.
Journal ArticleDOI
Airborne microorganisms emitted from wastewater treatment plant treating domestic wastewater and meat processing industry wastes
Anna Gotkowska-Płachta,Zofia Filipkowska,Ewa Korzeniewska,Wojciech Janczukowicz,Beverly A. Dixon,Iwona Gołaś,Damian Szwalgin +6 more
TL;DR: The presence of enteric bacteria, especially Enterobacteriaceae reflects the level of air pollution with bioaerosols from sewage and is an important factor during monitoring the quality of the air around WWTPs.
Journal ArticleDOI
Antibiotic Resistance of Bacterial Fish Pathogens
TL;DR: Alternatives to the currently used antimicrobial therapies are being evaluated for use in aquaculture, particularly the new fluoroquinolones and the third generation cephalosporins.
Journal ArticleDOI
The precision and robustness of published protocols for disc diffusion assays of antimicrobial agent susceptibility: an inter-laboratory study
Saoirse Nic Gabhainn,Øivind Bergh,Beverly A. Dixon,Linda Donachie,Jeremy Carson,Rosie Coyne,John Curtin,Inger Dalsgaard,Amedeo Manfrin,Grace Maxwell,Pete Smith +10 more
TL;DR: The overall precision of the protocols used here was found to be significantly lower than that implied by the control limits associated with the same bacterium in other validated disc diffusion protocols.